首页 › 基金 › Velan Capital Investment Management LP › NSRX

Velan Capital Investment Management LP 对 NSRX 的持仓历史

NASUS PHARMA LTD · 医疗保健

Velan Capital Investment Management LP 在 Q3 2026 的 13F 申报中披露持有 NSRX(NASUS PHARMA LTD)359,390 股,市值约 US$1.3M,约占其申报组合的 1.27%,在其申报持仓中市值排名第 16 位。 Velan Capital Investment Management LP 最近 3 个申报季度中有 3 个季度披露了 NSRX 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)359.39K 股
申报持仓市值$1.33M
组合权重1.27%
首次申报Q1 2026
最近变动持有
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Velan Capital Investment Management LP 对 NSRX 的持仓演变

Velan Capital Investment Management LP 于 Q1 2026 首次披露 NSRX 持仓:359,390 股(约 US$798K)。 该持仓在 Q3 2026 达到峰值 359,390 股,市值约 US$1.3M。 在 3 次申报中,Velan Capital Investment Management LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 359,390 股、市值约 US$1.3M。

逐季持仓明细

季度股数金额变化
Q1 2026 359.39K $797.85K 新进
Q2 2026 359.39K $1.26M 持有
Q3 2026 359.39K $1.33M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NSRX 与 13F 数据

NSRX(NASUS PHARMA LTD)属于医疗保健行业。我们追踪的基金中还有 8 只申报持有 NSRX。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NSRX 的基金

暂无其它被追踪基金申报持有 NSRX.

查看 NSRX 的全部基金持有人 →

常见问题

How long has Velan Capital Investment Management LP held NSRX?

Velan Capital Investment Management LP has disclosed NSRX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Velan Capital Investment Management LP's current position in NSRX?

As of Q3 2026, Velan Capital Investment Management LP holds 359.39K shares of NSRX (NASUS PHARMA LTD), valued at $1.33M, representing 1.27% of its reported portfolio and ranking #16.

Has Velan Capital Investment Management LP been buying or selling NSRX?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in NSRX. The position peaked in Q3 2026 at 359.39K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.